Akros Korea Shareholder Return High Dividend Index

Q1 2026 earnings release scheduled.

1Q 2026 earnings release scheduled for May 18, 2026. Analysts forecast a recovery in performance compared to the previous quarter, which is expected to have a medium impact on the stock price.

Q1 2026 earnings release on 2026-05-18; market analysts estimate typical quarterly results will have a low price impact expected.

Q1 2026 earnings release scheduled for 2026-05-17. Hanwha Investment & Securities analysts forecast revenue of KRW 1.34T (+13.8% YoY) and operating profit of KRW 251.9B (+19.3% YoY) estimated. Medium importance estimated as earnings typically drive significant price movement. Scheduled.

Daishin Securities is scheduled to release its Q1 2026 earnings report on May 15, 2026. Earnings releases typically cause significant price volatility, justifying a medium importance estimate scheduled.

Q1 2026 earnings release scheduled for 2026-05-14. Medium importance is estimated based on significant projected profit growth, and analysts forecast a consolidated net profit of KRW 751.8 billion, an 18% YoY increase, forecasted.

Medium importance estimated as quarterly results typically drive significant market interest and price volatility; Q1 2026 earnings release scheduled.

Celltrion is scheduled to announce its Q1 2026 earnings on May 8, 2026. Analysts forecast consolidated sales of approximately 1.12 trillion KRW and an operating profit of around 314 billion KRW, which is estimated to have a medium market impact (≥5%) scheduled.

Q1 2026 earnings release for May 8, 2026. Importance is estimated as Medium based on historical price volatility during earnings periods, scheduled.

Q1 2026 earnings release on May 7, 2026. Notable market impact is estimated upon announcement; scheduled

LG Uplus is scheduled to announce its Q1 2026 earnings on May 7, 2026. Analysts forecast positive results with potential year-over-year growth in revenue and operating profit; estimated Medium importance due to potential for significant earnings surprise, forecasted.

Estimated medium impact as earnings reports for major holding companies typically have significant market influence; Q1 2026 earnings release on 2026-05-06 scheduled.

Kangwon Land announced its Q1 2026 consolidated earnings on April 30, 2026, reporting revenue of KRW 378.9 billion (+3.4% YoY), operating profit of KRW 68.9 billion (-7.2% YoY), and net income of KRW 39.6 billion (-46.8% YoY). The significant 46.8% drop in net income is estimated to cause a price impact of 10% or more.

Celltrion applied for marketing authorization to the European Medicines Agency (EMA) for 'Herzuma SC', a subcutaneous formulation of its breast cancer biosimilar Trastuzumab, on April 30, 2026. This first-in-class formulation is estimated to have a high market impact (≥10%) due to its significant competitive advantage.

Announced Q1 2026 consolidated earnings, which fell significantly short of market expectations. The company reported revenue of KRW 388.8 billion and an operating profit of KRW 20.6 billion, a 65.5% decrease year-over-year. The 'earnings shock' was attributed to a slump in sales of mobile Display Driver ICs (DDI) and a base effect from high inventory demand in the prior year. High importance is estimated due to the significant earnings shock likely causing a price impact of 10% or more expected.

Announced Q1 2026 consolidated net profit of ₩211.4 billion, a 26.9% increase YoY. The Board also approved a ₩60 billion share buyback and cancellation for H1 2026, a 50% increase from the previous year.

On April 30, 2026, LG Uplus announced a plan to cancel 5.4 million treasury shares (1.26% of total shares), with the cancellation scheduled for May 15, 2026; estimated Medium importance as share cancellations typically boost shareholder value, scheduled.

Announced Q1 2026 consolidated results on April 30, 2026, with revenue of KRW 8.41 trillion and a record operating profit of KRW 357.5 billion (32.3% increase YoY), exceeding market forecasts. A positive market reaction is estimated due to record-breaking profitability expected.

Poongsan reported Q1 2026 consolidated results with revenue of KRW 1.27 trillion (+9.9% YoY) and operating profit of KRW 90.2 billion (+29.3% YoY). Despite the year-over-year growth, the results missed analyst expectations, causing a negative stock reaction on the day of the announcement.

On April 30, 2026, Medy-Tox's affiliate Numeco announced it had received product approval for its botulinum toxin 'Newlux' from the Ministry of Health of Ukraine, marking its third entry into a European country.

Announced a Q1 2026 cash dividend of ₩150 per share, a 25% increase from the same period last year. The decision was made at the Board of Directors meeting on April 30, 2026.

LX International Q1 2026 earnings results (Revenue KRW 4.21T, +4% YoY; OP KRW 108.9B, -6.8% YoY, +96.2% QoQ). Medium importance estimated due to significant QoQ recovery; scheduled

Announced on April 29, 2026, the company was included in the Dow Jones Sustainability World Index (DJSI) for the second consecutive year.

Stock price surged over 14% on April 28, 2026, amid expectations of reflective benefits from a competitor's production halt for mPPO, a material used in AI servers.

Annual dividend of 1,651 KRW per share for the 2025 fiscal year was paid on April 27, 2026.

Q1 2026 earnings announcement: Record revenue of KRW 29.5 trillion (+5.3% YoY), but operating profit fell 26.7% to KRW 2.2 trillion due to US tariffs and increased incentives; High importance estimated due to significant profit contraction, expected.

On April 24, 2026, the board of directors decided to change the management structure from a single CEO to a co-CEO system to enhance specialized and responsible management; medium impact expected due to significant governance change scheduled.

Announced Q1 2026 net profit of KRW 156.3 billion, a 15.3% decrease year-over-year, missing market expectations due to increased financing costs.

Cheil Worldwide announced its Q1 2026 earnings, reporting a 37.6% year-over-year decrease in operating profit to KRW 36.5 billion. The decline was attributed to one-off costs related to overseas business restructuring and changes in retirement benefit provisions.

Woori Financial Group announced Q1 2026 net profit of KRW 603.8 billion, a 2.1% decrease year-over-year, which was below market expectations; a 5-10% price impact is estimated and expected.

Announced a Q1 2026 cash dividend of KRW 220 per share, a 10% increase year-over-year, with the record date on May 11, 2026; a 1-5% price impact is estimated and scheduled.

Announced a plan to strengthen its securities subsidiary through a KRW 1 trillion capital increase and additional share buybacks in H2 2026; a 1-5% price impact is estimated and scheduled.